Ask Noah, the AI Agent for Life Science Professionals, via
[22] The existence of rare case reports of kidney failure and hypersensitivity reactions is noted in the United States prescribing information, but a causative role for sitagliptin has not been established
However, a number of challenges will need to be addressed over next years including a better understanding of the full potential of benefits and risks with the new obesity pharmacotherapies and ensuring wide and equal access for people living with obesity
A warehouse worker at a small company might have no access to weight loss peptide options through insurance, while an executive at a Fortune 500 company maintained full coverage with minimal out-of-pocket costs
If you're dealing with chronic inflammatory conditions, I encourage working with an experienced functional medicine practitioner who can help identify your unique triggers and develop a comprehensive treatment plan
Who qualifies to file a Saxenda lawsuit